Dr. Julie E. Reznicek, DO

  • Richmond, VA
  • Infectious disease specialist
NPI1932392479PAC ID8123212156
Medicare services, 2024
267
Medicare patients, 2024
133
Part D claims, 2024
566
Publications
7
MIPS score, 2024
84
Practice address
1250 East Marshall Street, Richmond, VA 23298
Practice phone
Call (804) 828-9000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

VCU Medical Center

Hospital · Richmond, Virginia

See all 4 affiliations

Find Dr. Reznicek's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Julie E. Reznicek is an infectious disease specialist in Richmond, Virginia

Dr. Reznicek practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Reznicek's NPI, 1932392479, was assigned on August 18, 2007. Dr. Reznicek graduated from Philadelphia College of Osteopathic Medicine in 2004. Dr. Reznicek holds Virginia license 0102204031.

NPI and contact details
Medicare PAC ID
8123212156
NPI enumeration date
August 18, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(804) 828-9000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
48
Medical school graduation
2004

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Julie E. Reznicek practices at VCU Medical Center in Richmond, Virginia

Dr. Reznicek's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

  • VCU Medical Center
    1250 East Marshall Street, Richmond, VA 23298 · Richmond CityPhone(804) 828-9000

Source: Dmand AI Affiliation Data

Dr. Julie E. Reznicek is affiliated with 3 sites of care and 1 medical group

Dr. Reznicek's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Reznicek is also affiliated with VCU Health Tappahannock Hospital. The medical group on file is MCV Physicians. Dmand AI also links Dr. Reznicek to 1 more urgent care center, named with a free account.

See all 4 affiliations for Dr. Reznicek

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Julie E. Reznicek's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reznicek practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
VCU Medical CenterAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Reznicek practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Commonwealth of Virginia and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Julie E. Reznicek is one of 210 infectious disease specialists in Virginia

Infectious disease is Dr. Reznicek's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Reznicek is licensed in Virginia.

Specialties and state licenses

  • Infectious disease, VirginiaPrimaryLicense 0102204031 · taxonomy 207RI0200X

Infectious disease specialists near Dr. Reznicek

Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Julie E. Reznicek billed Medicare for 267 services in 2024

CMS data shows 267 Medicare services from Dr. Reznicek across 7 procedure codes in 2024, for 133 Medicare patients. Medicare paid $20,434 for them.

Medicare services, 2024267
Medicare patients133
Paid by Medicare$20,434
Procedure codes7

Dr. Reznicek's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2112024: 2204%
Other services
2023: 02024: 47

Where Dr. Reznicek's Medicare services took place, 2024

  • In an office249%
  • In a facility24391%

Dr. Reznicek compared with the Virginia median for infectious disease specialists, 2024

  • Dr. Reznicek
  • Virginia median
Medicare services
267vs 32418% below
Medicare patients
133vs 15615% below
Part D claims
478vs 1463.3 times

Medians across 189 infectious disease specialists in Virginia with Dmand AI profiles that report each measure.

Dr. Reznicek's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Reznicek

Need commercial claims for Dr. Reznicek?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Reznicek and other infectious disease specialists in Virginia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Julie E. Reznicek treated 133 Medicare patients in 2024, average age 72

CMS counts 133 Medicare patients who saw Dr. Reznicek in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have arthritis, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reznicek's median patient age at 65, with 46% women.

Medicare patients, 2024133
Average age72
Average risk score2.58
Also on Medicaid17%

Dr. Reznicek's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Reznicek's Medicare patients by sex, 2024

  • Women6045%
  • Men7355%

Chronic conditions among Dr. Reznicek's Medicare patients, 2024

  1. Arthritis75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Mood disorders52%
  5. Depression49%
  6. Anxiety42%
  7. Ischemic heart disease42%
  8. Chronic kidney disease41%

Share of Medicare patients with each condition. A patient can have several.

Dr. Reznicek's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women46%
  • Men53%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Julie E. Reznicek wrote 566 Medicare Part D claims in 2024

In 2024, Dr. Reznicek wrote 566 Medicare Part D claims for 112 patients. 96% of them were for generic drugs. CMS names the drug for 478 of them, across 14 drugs with 11 or more claims each, at $55,814 in total drug cost. In 2023, CMS named 355 claims across 9 drugs.

Part D claims, 2024566
Drugs named by CMS14
Total drug cost$55,814
Part D patients112

Dr. Reznicek's Part D claims by kind of drug, 2024

  • Generic545 claims96%
  • Brand-name21 claims4%

Dr. Reznicek's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Reznicek's Part D claims, 2024

  • Antibiotics89%502 of 566 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3552024: 47835%

Drugs named by CMS: 14 in 2024, 9 in 2023.

See all prescribing by Dr. Reznicek

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Julie E. Reznicek scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Reznicek for performance year 2024, reported as part of a group. Dr. Reznicek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reznicek as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Reznicek's MIPS scores, performance year 2024

  • 84of 100Final score
  • 69.9of 100Quality
  • 99of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 77of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find infectious disease specialists like Dr. Reznicek by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Julie E. Reznicek has 7 publications on record

Dmand AI links 7 papers to Dr. Reznicek, published from 2020 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Immunoglobulin G. Dr. Reznicek's most frequent co-authors are Pamela Bailey, Michael Patrick Campbell, MD and Emily J. Godbout, DO.

Papers7
Years published2020 to 2025

Dr. Reznicek's papers by year, 2020 to 2025

Topics Dr. Reznicek writes about most

  • Immunoglobulin G

Dr. Reznicek's most frequent co-authors

Recent publications by Dr. Reznicek

See all 7 publications and co-authors

See who Dr. Reznicek researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Reznicek works with, so you can find a warm path to the right infectious disease specialists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Julie E. Reznicek received $4,804 in industry payments from 2018 to 2025

CMS Open Payments shows 12 general payments to Dr. Reznicek from 2 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 50% of the total. icotec Medical Inc. paid the most, $4,179.

General payments to Dr. Reznicek by program year, 2018 to 2025

General payments to Dr. Reznicek by kind, 2018 to 2025

$4.8Kin total
  • Consulting fees$2,42550%
  • Travel and lodging$1,89439%
  • Food and beverage$48510%

Companies that paid Dr. Reznicek the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Reznicek

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Julie E. Reznicek graduated from Philadelphia College of Osteopathic Medicine

Dr. Reznicek graduated from Philadelphia College of Osteopathic Medicine in 2004.

  1. Medical schoolPhiladelphia College of Osteopathic Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Julie E. Reznicek's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Julie E. Reznicek

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Julie E. Reznicek's NPI number?

Dr. Julie E. Reznicek's NPI number is 1932392479. It was assigned on August 18, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Julie E. Reznicek?

Dr. Julie E. Reznicek is an infectious disease specialist in Richmond, Virginia. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).

Where does Dr. Julie E. Reznicek practice?

Dr. Reznicek practices at 1250 East Marshall Street, Richmond, VA 23298. Dr. Reznicek's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dmand AI also links Dr. Reznicek to 1 urgent care center.

What is Dr. Julie E. Reznicek's office phone number?

The practice phone on file for Dr. Reznicek is (804) 828-9000.

What is Dr. Julie E. Reznicek's medical license number?

Dr. Reznicek holds Virginia license 0102204031.

Which hospitals is Dr. Julie E. Reznicek affiliated with?

Dr. Reznicek practices at VCU Medical Center in Richmond, Virginia. Dr. Reznicek is also affiliated with VCU Health Tappahannock Hospital.

What medical group is Dr. Julie E. Reznicek part of?

Dr. Reznicek is linked to MCV Physicians.

Does Dr. Julie E. Reznicek accept Medicare?

Yes. CMS data shows Dr. Reznicek billed Medicare for 267 services in 2024, and Dr. Reznicek accepts Medicare assignment.

Does Dr. Julie E. Reznicek offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Reznicek as offering telehealth services.

What is Dr. Julie E. Reznicek's MIPS score?

Dr. Reznicek's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Julie E. Reznicek see?

CMS counts 133 Medicare patients who saw Dr. Reznicek in 2024, with an average age of 72.

What services does Dr. Julie E. Reznicek bill to Medicare?

In 2024, Dr. Reznicek's most billed Medicare services were office visit, established patient (99213), hospital inpatient care (99223) and office visit, established patient (99214).

Where did Dr. Julie E. Reznicek go to medical school?

Dr. Reznicek graduated from Philadelphia College of Osteopathic Medicine in 2004.

What drugs does Dr. Julie E. Reznicek prescribe most?

In 2024 Medicare Part D data, Dr. Reznicek's most prescribed drugs by claims were Cephalexin, Amoxicillin and Doxycycline Hyclate.

Has Dr. Julie E. Reznicek received payments from drug or device companies?

CMS Open Payments shows $4,804 in general payments to Dr. Reznicek from 2 companies from 2018 to 2025. The largest total came from icotec Medical Inc.

How long has Dr. Julie E. Reznicek been practicing?

Dr. Reznicek graduated from medical school in 2004, 22 years ago.

Does Dr. Julie E. Reznicek do research?

Dmand AI links 7 publications to Dr. Reznicek, published from 2020 to 2025.

Who does Dr. Julie E. Reznicek publish with?

Dr. Reznicek's most frequent co-authors are Pamela Bailey (2 shared papers), Michael Patrick Campbell, MD (1 shared paper) and Emily J. Godbout, DO (1 shared paper).

Selling to infectious disease practices?

See infectious disease specialists in Virginia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)